Ask AI
ProCE Banner Series

Overcoming Barriers to Timely Diagnosis and Classification of Interstitial Lung Disease: Considerations for Radiologists

Learn about making timely and accurate diagnoses of ILD, review radiologic patterns, and discuss the importance of multidisciplinary care.

  AMA
Credits Available

1.0

Who Should Attend

This educational initiative is intended for community- and academic-based Radiologists other healthcare providers who care for patients with or at risk for Interstitial Lung Disease (ILD).

All Events

Overcoming Barriers to Timely Diagnosis and Classification of Interstitial Lung Disease: Considerations for Radiologists

Past Events

September

14

2023

5:30 PM - 6:30 PM Pacific Time (PT)

Virtual

Topics

Agenda

  • Welcome and Preactivity Questions
  • Incidental Identification of ILAs
  • Focus on Fibrosing ILD: Vital Information for Radiologists
  • Radiologist and Multidisciplinary Discussion for ILD Diagnosis
  • Conclusion and Postactivity Questions
  • Question and Answer Session

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
The goal of this activity is to improve the knowledge and competence of Radiologists in timely in accurate diagnosis of ILD including identification, referral, and follow-up of ILA, as well as radiologic patterns consistent with fibrosis ILDs and importance of MDD in the diagnosis and classification of ILD.

Target Audience
This educational initiative is intended for community- and academic-based Radiologists other healthcare providers who care for patients with or at risk for Interstitial Lung Disease (ILD). 

Learning Objectives:

  • Construct a follow-up and referral plan for identified ILA in the context of patient-specific characteristics
  • Identify clinical and imaging patterns used in the diagnosis and classification of ILD
  • Integrate current guideline-based HRCT patterns necessary for the diagnosis of idiopathic pulmonary fibrosis
  • Discuss how MDD improves accuracy and confidence in making the diagnosis and classification of ILD

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC

This activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Contact Clinical Care Options

For customer support please click here.

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191